Recombinant Cyclin B1 antibody
Quick Overview for Recombinant Cyclin B1 antibody (ABIN7127121)
Target
See all Cyclin B1 (CCNB1) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- It recognizes a protein of 55-62 kDa, identified as cyclin B1. In mammals, cyclin B associates with inactive p34cdc2, which facilitates phosphorylation of p34cdc2 at aa 14Thr and 15Tyr. This maintains the inactive state until the end of G2-phase. The inactive cyclin B-p34cdc2 complex continues to accumulate in the cytoplasm until the completion of DNA synthesis, when Cdc25, a specific protein phosphatase, dephosphorylates aa 14Thr and 15Tyr of p34cdc2 rendering the complex active at the G2/M boundary. This mitotic kinase complex remains active until the metaphase/anaphase transition when cyclin B is degraded. This degradation process is ubiquitin-dependent and is necessary for the cell to exit mitosis. So, cyclin B-p34cdc2 plays a critical role in G2 to M transition.
-
Cross-Reactivity (Details)
- Human, Mouse and Hamster.
-
Purification
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
Immunogen
- Recombinant full-length human CCNB1 protein
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Known_Application: Optimal dilution for a specific application should be determined.
Positive_Control: Cell line in logarithmic growth phase. Human tonsil, prostate or ovarian carcinoma.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
Preservative
- Azide free
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
Expiry Date
- 24 months
-
-
- Cyclin B1 (CCNB1)
-
Alternative Name
- CCNB1
-
Background
-
CCNB, CCNB1, CCNB1_HUMAN, G2 Mitotic Specific Cyclin B1,Cyclin B1 (G2- & M-phase Cyclin)
Cellular localisation: Cytoplasm. -
Molecular Weight
- 55-62kDa
-
Gene ID
- 891, 23960
-
UniProt
- P14635
-
Pathways
- Cell Division Cycle, AMPK Signaling, Mitotic G1-G1/S Phases, M Phase
Target
-